skip to Main Content

Importance of Blood Draw in Infliximab Dosing

Blood tests are critical in the medical field for a variety of reasons. Specifically, blood tests can help doctors evaluate how well the organs are working, diagnose diseases, and assess how well…

Read More

iDose vs. T3

Baysient’s web-based applications, iDose and T3 were specifically developed to facilitate the dosing of biological agents by integrating real patient’s clinical characteristics. Both softwares use Bayesian models, routine lab results, and demographics…

Read More

How T3 Fixes IV Infliximab Dosing

IV Infliximab, a monoclonal antibody, has emerged as an efficient treatment with many clinical benefits, such as quick disease activity reduction and IBD patient life quality improvement. However, drug development of infliximab…

Read More

Marla C. Dubinsky, MD, Discusses Unique and Personalized Gastroenterology Care

Dr. Marla Dubinsky discusses the unique, personalized, and integrated care offered for children at the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center in a video posted by Mount Sinai Health…

Read More

Ankylosing Spondylitis Awareness Month

Ankylosing Spondylitis Awareness Month is observed every April. This month is dedicated to raising awareness and recognizing arthritis and other associated illnesses such as ankylosing spondylitis.  What is Ankylosing Spondylitis? Ankylosing spondylitis,…

Read More

Understanding How Bayesian Modeling Works

The right dose of medicine is crucial when it comes to the treatment process. For patients with inflammatory bowel disease (IBD), the wrong dose can cause patients to lose response to Infliximab…

Read More

History of Precision Medicine

Precision dosing focuses on the individualization of drug treatment regimens based on drug attributes, pharmacokinetic/pharmacodynamic variability, disease state characteristics, and patient-specific factors. Before precision dosing, pharmaceutical medicine adopted a one-size-fits-all approach that…

Read More

Precision Medicine in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) describes a group of disorders that cause the intestines to become inflamed. There are two main types of IBD: ulcerative colitis and Crohn’s disease. These two types of…

Read More

Challenges When Treating IBD with Biologics Based on the Standard Dosing

Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. The two main types of IBD are Crohn’s disease (CD) and ulcerative…

Read More

Ulcerative Colitis vs. Crohn’s Disease

Inflammatory bowel disease (IBD), is primarily composed of Crohn’s disease (CD) and ulcerative colitis (UC) and affects as many as 1.6 million Americans, with approximately 30,000 new cases diagnosed each year. Both…

Read More
Model-Informed-Precision-Dosing-How-It-Works

Model-Informed Precision Dosing: How It Works

Model-informed precision dosing (MIPD)  involves modeling and simulation to predict the necessary drug dose for a given patient based on their individual characteristics that are most likely to improve efficacy and/or lower…

Read More

Baysient’s Comments on ICER’s Draft Evidence Report

The Institute for Clinical and Economic Review (ICER) systematically reviewed and synthesized existing evidence from clinical studies to assess the comparative clinical effectiveness for targeted immune modulators (TIMs) for moderate-to-severe ulcerative colitis…

Read More

The Need for Precision Dosing

Precision dosing focuses on the individualization of drug treatment regimens based on drug attributes, pharmacokinetic/pharmacodynamic variability, disease state characteristics, and patient-specific factors. This concept of dosing offers the hope of optimizing treatment…

Read More

Study on Optimization of Infliximab Therapy in Inflammatory Bowel Disease Using iDose

Therapy with biologics has brought a paradigm shift in the management of inflammatory bowel disease (IBD). Infliximab (IFX) has remained one of the key drugs for therapy in IBD. Despite Infliximab’s therapeutic…

Read More

Adam Cheifetz, MD, Proactive vs. Reactive Therapeutic Drug Monitoring – Which Method is Best?

In a recent podcast on Podcasts360, Adam Cheifetz, MD, a cochair of the virtual Interdisciplinary Autoimmune Summit (IAS) 2020, gave an overview of his presentation on how proactive and reactive therapeutic drug…

Read More

Baysient’s iDose System Featured in Gastroenterology & Endoscopy News Article

Marla Dubinsky, MD, Discusses Patient Success with Dashboard-Guided Infliximab Induction in Gastroenterology & Endoscopy News Article Baysient’s patented iDose system uses Bayesian models, laboratory data, and demographics to individualize Infliximab dosing, effectively…

Read More

Treating Inflammatory Diseases: A Brief History

For many years, Crohn’s disease and IBD went widely misunderstood and unrecognized. In fact, early doctors could not differentiate between IBD and diarrheal diseases caused by infectious agents. It wasn’t until 1932…

Read More

Clinical Benefits of Precision Dosing

When it comes to drug therapy, there is no one right dose for all patients. Each patient is unique and deserves individual treatments tailored specifically for them. Precision dosing has been shown…

Read More

Top Down Dosing With iDose by Baysient

Marla Dubinsky, MD, Speaks on Proactive Therapeutic Monitoring During a recent podcast on Podcasts360, Marla Dubinsky, MD, discussed how her research on measuring drug concentrations and anti-drug antibodies along with algorithmic approaches…

Read More
How Precision Dosing Lowers Overall Healthcare Costs

How Precision Dosing Lowers Overall Healthcare Costs

Medication plays an essential role in healthcare, but it also is a significant element in the increasing cost of health care. Precision dosing, also referred to as individualized dosing, utilizes drug attributes,…

Read More
Baysient- Precision Dosing and Remission

Precision Dosing and Remission

At Baysient, it is our mission to help patients achieve remission from their inflammatory diseases. The traditional dosing process for such conditions leads to expensive medical costs overall and makes long-term remission…

Read More
Baysient- Living with IBD

Living with IBD

Inflammatory Bowel Disease (IBD) represents a group of chronic intestinal conditions, such as ulcerative colitis and Crohn’s disease. These disorders cause prolonged inflammation in the digestive tract, leading to uncomfortable and sometimes…

Read More
Current iDose Compatible Conditions

Current iDose Compatible Conditions

Baysient’s revolutionary iDose software calculates a precise, model-informed dose of medication to help patients reach, and stay in, remission. We understand that all patients are unique and deserve customized therapies to drive…

Read More

Baysient’s Commitment to COVID-19 Safety

Coronavirus (COVID-19) is officially a worldwide pandemic as it continues to spread globally. The doctors and researchers on the Baysient team are actively developing treatments for COVID-19 to help end the death…

Read More

Digital Health Company Baysient Announces CDS/HCEI Software to Reduce Healthcare Cost in the Biosimilar Market

Ft. Myers FL, February 28, 2020 - Baysient® LLC’s founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics…

Read More

Canadian Digestive Diseases Week

Canadian Digestive Diseases Week (CDDW) is Canada’s premier educational conference, showcasing the newest research in gastroenterology and hepatology.
Read More

Schedule a Demo

Interested in how iDose can improve your patient outcomes?

Back To Top